NIH-funded research NIH-funded research

AI-powered CKD risk predictor and care tool

Official title: Artificial Intelligence-based & Ethically-focused Multi-Modal Data Integration Framework for Screening, Diagnosing, and Caring for CKD Patients

Funded at University of Florida · NIH-11556752 · Data updated 2026-11-12

A cloud-based AI tool will combine medical records, images, and pathology data to predict a patient’s 5-year CKD risk and highlight modifiable factors to guide care.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startSeptember 1, 2025
Project endAugust 31, 2027
Funding year2026
Award (this year)$1,962,384
NIH project number3OT2OD038014-01S1
Project IDNIH-11556752 on NIH RePORTER

Who could benefit from this research

Could help

Adults with chronic kidney disease who have or will generate data across EHR, imaging, and pathology datasets may be eligible.

Less likely to help

Patients with CKD for whom comprehensive multi-modal data are not available or usable by the AI system may receive limited or no benefit.

What this research studies

If you have chronic kidney disease, this project aims to build an AI system that uses your health records, lab results, radiology images, and pathology slides to forecast how your kidney disease might progress over five years. The tool will break down large pathology images into many small parts to learn from detailed tissue patterns and combine this with other data types for accurate predictions. It is designed to assist primary care doctors and nephrologists in prioritizing treatments and helping patients focus on the most impactful risk factors. The ultimate goal is to provide personalized risk profiles that support timely, informed decisions about managing CKD.

Why it matters

Potential benefit: If successful, patients could receive more precise risk estimates and personalized guidance to reduce progression and complications.

How similar studies have gone: Related efforts show promise for multi-modal AI in healthcare, but applying it specifically to CKD progression with histopathology is an emerging approach.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Sarder, Pinaki — University of Florida
  • Study coordinator: Sarder, Pinaki

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.